Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BCR expression
i
Other names:
BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
613
Related biomarkers:
Mutation
Fusion
Others
‹
BCR-ABL1 F317I + ABL1 F317C (1)
BCR-ABL1 F317I + ABL1 F317C + ABL1 F1317L (1)
BCR-ABL1 T315I + ABL1 E255K (1)
BCR-ABL1 T315I + ABL1 E255V (1)
BCR-ABL1 fusion + SET underexpression (1)
BCR-ABL1 F317I + ABL1 F317C (1)
BCR-ABL1 F317I + ABL1 F317C + ABL1 F1317L (1)
BCR-ABL1 T315I + ABL1 E255K (1)
BCR-ABL1 T315I + ABL1 E255V (1)
BCR-ABL1 fusion + SET underexpression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BCR expression
Acute Myelogenous Leukemia
BCR expression
Acute Myelogenous Leukemia
nilotinib
Sensitive: C3 – Early Trials
nilotinib
Sensitive
:
C3
nilotinib
Sensitive: C3 – Early Trials
nilotinib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.